The 2.0 A resolution crystal structure of prostaglandin H2 synthase-1:: Structural insights into an unusual peroxidase

被引:95
作者
Gupta, K
Selinsky, BS
Kaub, CJ
Katz, AK
Loll, PJ
机构
[1] Drexel Univ, Coll Med, Dept Biochem, Philadelphia, PA 19102 USA
[2] Univ Penn, Grad Grp Pharmacol Sci, Philadelphia, PA 19104 USA
[3] Villanova Univ, Dept Chem, Villanova, PA 19085 USA
关键词
cyclooxygenase; non-steroidal anti-inflammatory drug; peroxidase; prostaglandin synthase; membrane binding domain;
D O I
10.1016/j.jmb.2003.10.073
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Prostaglandin H-2 synthase (EC 1.14.99.1) is an integral membrane enzyme containing a cyclooxygenase site, which is the target for the non-steroidal anti-inflammatory drugs, and a spatially distinct peroxidase site. Previous crystallographic studies of this clinically important drug target have been hindered by low resolution. We present here the 2.0 Angstrom resolution X-ray crystal structure of ovine prostaglandin H-2 synthase-1 in complex with alpha-methyl-4-biphenylacetic-methyl-4-biphenylacetic acid, a defluorinated analog of the non- steroidal anti-inflammatory drug flurbiprofen. Detergent molecules are seen to bind to the proteins membrane-binding domain, and their positions suggest the depth to which this domain is likely to penetrate into the lipid bilayer. The relation of the enzyme's proximal heme ligand His388 to the heme iron is atypical for a peroxidase; the iron-histidine bond is unusually long and a substantial tilt angle is observed between the heme and imidazole planes. A molecule of glycerol, used as a cryoprotectant during diffraction experiments, is seen to bind in the peroxidase site, offering the first view of any ligand in this active site. Insights gained from glycerol binding may prove useful in the design of a peroxidase-specific ligand. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:503 / 518
页数:16
相关论文
共 95 条
[1]   Structural properties of peroxidases [J].
Banci, L .
JOURNAL OF BIOTECHNOLOGY, 1997, 53 (2-3) :253-263
[2]   FACTORING OF THE HYPERFINE SHIFTS IN THE CYANIDE ADDUCT OF LIGNIN PEROXIDASE FROM P-CHRYSOSPORIUM [J].
BANCI, L ;
BERTINI, I ;
PIERATTELLI, R ;
TIEN, M ;
VILA, AJ .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1995, 117 (33) :8659-8667
[3]   Antispasmodics. V [J].
Blicke, FF ;
Grier, N .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1943, 65 :1725-1728
[4]   Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling [J].
Bracey, MH ;
Hanson, MA ;
Masuda, KR ;
Stevens, RC ;
Cravatt, BF .
SCIENCE, 2002, 298 (5599) :1793-1796
[5]  
Breitner JCS, 1996, ANNU REV MED, V47, P401
[6]   A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors [J].
Brideau, C ;
Kargman, S ;
Liu, S ;
Dallob, AL ;
Ehrich, EW ;
Rodger, IW ;
Chan, CC .
INFLAMMATION RESEARCH, 1996, 45 (02) :68-74
[7]  
Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
[8]   Structural changes in a cryo-cooled protein crystal owing to radiation damage [J].
Burmeister, WP .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2000, 56 :328-341
[9]   EPIDERMAL GROWTH FACTOR-LIKE MODULES [J].
CAMPBELL, ID ;
BORK, P .
CURRENT OPINION IN STRUCTURAL BIOLOGY, 1993, 3 (03) :385-392
[10]   The crystal structure of lignin peroxidase at 1.70 Å resolution reveals a hydroxy group on the Cβ of tryptophan 171:: A novel radical site formed during the redox cycle [J].
Choinowski, T ;
Blodig, W ;
Winterhalter, KH ;
Piontek, K .
JOURNAL OF MOLECULAR BIOLOGY, 1999, 286 (03) :809-827